logo

CLPT

ClearPoint Neuro·NASDAQ
--
--(--)
--
--(--)
1.04 / 10
Underperform

Fundamental analysis of CLPT reveals a weak profile with a 1.0/10 strength rating. Key deficits include negative Cash-MV (-0.0663) and ROA (-35.67 %), both in the first performance group, indicating poor historical returns. Revenue-MV is also negative (-2.3435), limiting growth prospects. Only Profit-MV (0.4743) and Net income-Revenue (-0.1516) show mixed signals, but they are insufficient to offset the weaknesses, warranting a defensive stance.

Fundamental(1.04)SentimentTechnical

Analysis Checks(5/10)

Revenue-MV
Value-2.34
Score3/3
Weight-5.41%
1M Return1.11%
ROA (%)
Value-35.67
Score0/3
Weight21.46%
1M Return-7.20%
Net cash flow from operating activities / Operating revenue (%)
Value-44.60
Score1/3
Weight10.13%
1M Return-2.56%
Profit-MV
Value0.47
Score2/3
Weight-15.50%
1M Return2.92%
Net income-Revenue
Value-0.15
Score2/3
Weight9.66%
1M Return-2.32%
Cash-UP
Value-0.05
Score2/3
Weight17.00%
1M Return-4.39%
Annualized net profit margin on total assets (%)
Value-47.56
Score0/3
Weight21.46%
1M Return-7.20%
Asset-MV
Value-0.51
Score0/3
Weight15.56%
1M Return-3.74%
Cash-MV
Value-0.07
Score1/3
Weight18.71%
1M Return-5.27%
Net profit / Total profit (%)
Value100.29
Score2/3
Weight6.93%
1M Return-1.55%
Is CLPT fundamentally strong?
  • CLPT scores 1.04/10 on fundamentals and holds a Premium valuation at present. Backed by its -86.05% ROE, -67.40% net margin, -16.53 P/E ratio, 24.10 P/B ratio, and -20.29% earnings growth, these metrics solidify its Underperform investment rating.